SRS188 - National outcomes in simultaneous pancreas–kidney transplantation: the role of HLA mismatch and induction therapy

View at publisher Summarise with VIRAT
Authors: Abdullah Khalid Malik, Jenni Banks, Claire Counter, Lewis Simmonds, Samuel James Tingle, Sanjay Sinha, Anand Muthasamy, Andrew Sutherland, John Casey, Martin W. Drage, David van Dellen, Chris J. Callaghan
+7 more Doruk Elker, D. M. Manas, Gavin J. Pettigrew, Neil Russell, N. Sheerin, Colin Wilson, Steven White
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract Background Simultaneous pancreas–kidney (SPK) transplantation offers the best long-term survival for selected patients with insulin-dependent diabetes and end-stage renal disease. However, determinants of pancreas graft survival remain incompletely defined, particularly the role of HLA mismatch and induction therapy. Methods We analysed all SPK transplants in the UK between April 2007–March 2019 using data extracted from the UK Transplant Registry. Multivariable Cox proportional hazards models assessed the impact of locus-specific HLA mismatch and induction therapy (Alemtuzumab versus Basiliximab) on pancreas, kidney, and patient survival, adjusted for donor, recipient, and transplant factors. Results Among 1705 SPK recipients, pancreas graft survival was 88.6, 81.3, and 72.7% at 1, 5, and 10 years, respectively. Kidney graft and patient survival at 10 years were 76.7 and 75.3%. Independent predictors of pancreas graft loss included donor age, cold ischaemic time, and HLA-DQ mismatch. Unexpectedly, recipients with a DQ mismatch had improved long-term pancreas graft survival compared with those with no mismatch (HR 0.75, 95% c.i. 0.59–0.94, P = 0.033). This protective effect was not observed for kidney or patient outcomes. Induction therapy type did not significantly influence survival on adjusted analyses. Conclusions In this first national analysis of HLA and induction in SPK transplantation, DQ mismatch was associated with superior long-term pancreas graft survival. This novel finding warrants mechanistic investigation and may inform future allocation and immunogenetic strategies in pancreas transplantation.

Fields of Study & Subjects

Renal Transplantation Outcomes and Treatments Transplantation: Methods and Outcomes Organ Transplantation Techniques and Outcomes

Publication details

Journal / source
British journal of surgery
Volume
113
Issue
Supplement_2
Publication date
1 March 2026
Language
EN